Live Breaking News & Updates on பொது உறவுகள் க்கு ஆராய்ச்சி கல்வி

Stay updated with breaking news from பொது உறவுகள் க்கு ஆராய்ச்சி கல்வி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nanotechnology Now - Press Release: New 3D-Bioprinter + Bioink Use Living Cells Straight From Culture Plate: Cell models mimicking natural tissue topography herald new era for biomedical research


Our NanoNews Digest Sponsors
Home > Press > New 3D-Bioprinter + Bioink Use Living Cells Straight From Culture Plate: Cell models mimicking natural tissue topography herald new era for biomedical research
Abstract:
The combination of a 2-Photon 3D-printer with an innovative hydrogel-based bioink allows the direct printing of 3D structures containing living cells at both the meso- and microscale. Developed by UpNano GmbH (Vienna, Austria), the NanoOne Bio is a printer based on the successful NanoOne range of laser-powered 2-Photon 3D-printers that are able to build structures across 12 orders of magnitude. The new hydrogel has been developed with Xpect INX (Ghent, Belgium), a spin-off in foundation specialized in the development of biocompatible materials for the 3D-(bio-)printing industry. It is the only commercially available resin that allows embedding living cells straight from a culture plate within highly precise 3D-printed structures for biological applications. ....

Denise Mandt , Jamesj Yoo , Forschung Bildung Gmb , Peter Gruber , Nanoone Bio , Jasper Van Hoorick , Barbara Bauder , Large Sample Atomic Force Microscope , Head Marketing Business Development , Ghent University , Imaging Center , Public Relations For Research Education , Sheet Microscopes At Major Comprehensive Cancer Center , Wave Inc , Business Development , Home Press , Upnano Gmbh , Wake Forest Institute , Regenerative Medicine , United States , Advisory Board , Public Relations , Nanotechnology Now , Large Sample Atomic Force Microscope March , Light Sheet Microscopes , Major Comprehensive Cancer Center ,

Immunodiagnostics and Vaccine Development at Viravaxx AG Gain Momentum


Search jobs
Immunodiagnostics and Vaccine Development at Viravaxx AG Gain Momentum
Vienna (Austria), Jan 11, 2021. Fast-track development of vaccines against COVID-19 and other infectious diseases are facilitated by microarray-based assays for whole-proteome analysis and vaccine design platforms. Both have been developed by Viravaxx AG, and the company’s recent progress with its SARS-CoV-2 Interaction Assay offered a turning point.
 
Concomitantly, as of Jan 1, 2021, Viravaxx has recruited Dr. Helmut Brunar as its new CEO. Dr. Brunar brings vast expertise in vaccines, cell-therapies and diagnostic products to the company. Before joining Viravaxx, he managed supply chain activities at Johnson & Johnson’s COVID-19 vaccine program. Prior to this, he was CEO & Chairman with Axentis Pharma AG where he built a team to develop respiratory drug candidate AX-TOBRA. Dr. Brunar will take over from Dr. Rainer Henning, who has made invaluable co ....

Helmut Brunar , Trainer Henning , Frank Stolz , Rudolf Valenta , Barbara Bauder , Public Relations For Research Education , University Of Vienna , Axentis Pharma , Medical University , Public Relations , மழை கோழி , வெளிப்படையான ஸ்த்தொல்ஜ் , ருடால்ப் வாலண்டா , பார்பரா பவுடர் , பொது உறவுகள் க்கு ஆராய்ச்சி கல்வி , பல்கலைக்கழகம் ஆஃப் வியன்னா , மருத்துவ பல்கலைக்கழகம் , பொது உறவுகள் ,